These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16955195)

  • 1. Hydroxychloroquine in psoriasis: is it really harmful?
    Sorbara S; Cozzani E; Rebora A; Parodi A
    Acta Derm Venereol; 2006; 86(5):450-1. PubMed ID: 16955195
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis coexisting with subacute cutaneous lupus erythematosus.
    Kontochristopoulos GJ; Giannadaki M; Doulaveri G; Christofidou E; Zakopoulou N
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):385-6. PubMed ID: 15096170
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus.
    Ezra N; Jorizzo J
    Clin Exp Dermatol; 2012 Jun; 37(4):327-34. PubMed ID: 22582908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
    Pinto-Almeida T; Sanches M; Alves R; Selores M
    Dermatol Online J; 2012 Aug; 18(8):13. PubMed ID: 22948063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
    González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
    Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosacea-like cutaneous lupus erythematosus: an atypical presentation responding to antimalarials.
    Marzano AV; Lazzari R; Polloni I; Boneschi V; Crosti C
    Acta Derm Venereol; 2013 Jan; 93(1):106-7. PubMed ID: 23053047
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effect of hydroxychloroquine on cutaneous lupus erythematosus in a Japanese girl.
    Yamamoto T; Hiraiwa T
    J Dermatol; 2014 Apr; 41(4):357-9. PubMed ID: 24617496
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to hydroxychloroquine due to smoking in a patient with lupus erythematosus tumidus.
    Hügel R; Schwarz T; Gläser R
    Br J Dermatol; 2007 Nov; 157(5):1081-3. PubMed ID: 17854374
    [No Abstract]   [Full Text] [Related]  

  • 10. [Subacute lupus erythematosus and psoriasis].
    Borbujo J; Calvo JP; Cortés L; Zamora E
    Rev Clin Esp; 1998 Feb; 198(2):116. PubMed ID: 9558928
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus.
    Mazgaj M; Picard-Dahan C; Deschamps L; Marinho E; Estève E; Descamps V
    Int J Dermatol; 2020 Apr; 59(4):e118-e120. PubMed ID: 31957866
    [No Abstract]   [Full Text] [Related]  

  • 12. Coexistent psoriasis and lupus erythematosus treated with alefacept.
    Berthelot C; Nash J; Duvic M
    Am J Clin Dermatol; 2007; 8(1):47-50. PubMed ID: 17298107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simultaneous incidence of psoriasis and lupus erythematosus and their treatment].
    Ladanyi E; Nagy E
    Z Hautkr; 1977 Jul; 52(14):736-8. PubMed ID: 899109
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of antimalarial-refractory cutaneous lupus erythematosus.
    Callen JP
    Lupus; 1997; 6(2):203-8. PubMed ID: 9061669
    [No Abstract]   [Full Text] [Related]  

  • 15. Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus".
    Callen JP
    Arch Dermatol; 2011 Nov; 147(11):1267-8. PubMed ID: 22106112
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apremilast for the Treatment of Concomitant Subacute Cutaneous Lupus Erythematosus and Psoriasis.
    Tsiogka A; Gerochristou M; Agrogianni A; Gregoriou S; Rigopoulos D; Kontochristopoulos G
    Skinmed; 2022; 20(5):391-392. PubMed ID: 36314710
    [No Abstract]   [Full Text] [Related]  

  • 18. Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus.
    Creel N; Werth V
    J Drugs Dermatol; 2005; 4(2):225-7. PubMed ID: 15776783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coexistence of subacute cutaneous lupus erythematosus and psoriasis.
    Ferahbas A; Utas S; Canoz O; Atasavun C
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):390-1. PubMed ID: 15096174
    [No Abstract]   [Full Text] [Related]  

  • 20. Linear cutaneous lupus erythematosus in the lines of Blaschko.
    Engelman DE; Kotz EA; Maize JC
    Pediatr Dermatol; 2007; 24(2):125-9. PubMed ID: 17461806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.